webleads-tracker

EFPIA director Richard Bergström | Learning the Lessons From the US on Disclosure

Pharma Compliance Info EFPIA director Richard Bergström | Learning the Lessons From the US on Disclosure EFPIA   The US Open Payments database got off to a less than happy start. EFPIA will tap into this experience to inform implementation of the code on disclosure in Europe, says Richard Bergström, Director General of EFPIA.
There are two big differences between the US and Europe in moves to disclose transfers of value from pharma companies to healthcare professionals.
The first is that the US created a legal requirement to disclose under the Sunshine Act, whereas for the most part, disclosure will be voluntary in Europe.
The second difference is that of scale, with the Centers for Medicare and Medicaid Services (CMS) setting up a single, centralised database for all US records, a technical feat that has not gone smoothly.
Despite these significant differences, Richard Bergström, Director General of EFPIA believes Europe should look to the US experience, as it moves towards the implementation of the voluntary code on disclosure of transfers of value at the start of 2015. “After talking to colleagues in the US, I am clear there are important lessons for us,” he says.
To read the article by Richard Bergström

Check Also

Pharma Compliance Info Belgique | Arrêté royal portant exécution du Sunshine Act EFPIA

Belgique | Arrêté royal portant exécution du Sunshine Act

PHILIPPE, Roi des Belges, A tous, présents et à venir, Salut. Vu l’article 108 de …

X